Clinicopathological analysis for recurrence of stage Ib gastric cancer (according to the second English edition of the Japanese classification of gastric carcinoma)

Gastric Cancer

Volumn 14, Issue 4, 2011, Pages 372-377

  Yokoyama, Takashi ^a,b   Kamada, Kiyoshi ^a   Tsurui, Yoshikazu ^a   Kashizuka, Hisanori ^a   Okano, Eiji ^a   Ogawa, Sanehito ^a   Obara, Shinsaku ^a   Tatsumi, Mitsutoshi ^a  

^a HOSHIGAOKA KOSEINENKIN HOSPITAL   (Japan)

^b Takanohara Central Hospital   (Japan)

Author keywords

Adjuvant chemotherapy; Gastric carcinoma; Prognostic factor; Recurrence; Stage I

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STOMACH CARCINOMA; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; UNDIFFERENTIATED CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; GASTRECTOMY; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECURRENCE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84855713364     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0051-3     Document Type: Article

References (16)

1. Ohtsu A, Yoshida S, Saijo N. Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol. 2006;24: 2188-96. (Pubitemid 46630691)
2. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd English edition. Gastric Cancer 1998;1: 10-24.
3. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357: 1810-20. (Pubitemid 350044801)
4. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000; 87:236-42. (Pubitemid 30088655)
5. Sakar B, Karagol H, Gumus M, Basaran M, Kaytan E, Argon A, et al. Timing of death from tumor recurrence after curative gastrectomy for gastric cancer. Am J Clin Oncol. 2004;27:205-9. (Pubitemid 38451484)
6. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449-61. (Pubitemid 30194389)
7. Kim JW, Hwang I, Kim MJ, Jang SJ. Clinicopathological characteristics and predictive markers of early gastric cancer with recurrence. J Korean Med Sci. 2009;24:1158-64.
8. Folli S, Dente M, Dell'Amore D, Gaudio M, Nanni O, Saragoni L, et al. Early gastric cancer; prognostic factors in 223 patients. Br J Surg. 1995;82:952-6.
9. Ichiyoshi Y, Toda T, Minamisono Y, Nagasaki S, Yakeishi Y, Sugimachi K. Recurrence in early gastric cancer. Surgery. 1990; 107:489-95. (Pubitemid 20156649)
10. Lawrence M, Shiu MH. Early gastric cancer. Twenty-eight-year experience. Ann Surg. 1991;213:327-34.
11. Lee HJ, Kim YH, Lee KU, Lee KU, Choe KJ, Kim JP, et al. Clinicopathological analysis for recurrence of early gastric cancer. Jpn J Clin Oncol. 2003;33:209-14. (Pubitemid 43115260)
12. Takeuchi H, Kakeji Y, Tokunaga E, Koga T, Maehara Y, Sugimachi K. Prediction of recurrence after curative resection of gastric carcinoma invading the muscularis propria: A multivariate analysis. Gastric Cancer. 2000;3:28-32. (Pubitemid 32182891)
13. Moriguchi S, Maehara Y, Korenaga D, Sugimachi K, Nose Y. Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol. 1992;1:341-6.
14. Fink AS, Longmire WP. Carcinoma of stomach. In: Subiston DC, editor. Textbook of surgery. 14th ed. Philadelphia: WB Saunders; 1991. p. 814-27.
15. Marutsuka T, Shimada S, Shiomori K, Hayashi N, Yagi Y, Yamane T, et al.Mechanisms of peritonealmetastasis after operation for nonserosa- invasive gastric carcinoma: An ultrarapid detection systemfor intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res. 2003;9:678-85. (Pubitemid 36182600)
16. Koizumi W, Kurihara M, Nakano S, Hasegawa K. Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology. 2000;58:191-7. (Pubitemid 30189900)